Literature DB >> 22142873

Death in the United States, 2009.

Arialdi M Miniño1.   

Abstract

Mortality in the United States is best summarized by the age-adjusted death rate--a measure that accounts for changes in the age distribution of the population. This rate has declined in an almost uninterrupted manner since 1960. The death rate is now 45 percent lower than in 1960 (declining from 1,339.2 per 100,000 standard population in 1960 to 741.0 in 2009). Although age-adjusted mortality has declined for all demographic groups over a period of many decades, long-standing gaps between black and white populations and between male and female populations have begun to narrow only since the mid-1990s. Many of the recent improvements in death rates and life expectancy for all population groups can be attributed to ongoing reductions in death rates from major causes of death, such as heart disease, cancer, stroke, and chronic lower respiratory diseases. The figures presented in this report are based on preliminary mortality data for 2009. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Year:  2011        PMID: 22142873

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  29 in total

1.  Mucociliary Clearance in Former Tobacco Smokers with Both Chronic Obstructive Pulmonary Disease and Chronic Bronchitis and the Effect of Roflumilast.

Authors:  Beth L Laube; Kathryn A Carson; Gail Sharpless; Laura M Paulin; Nadia N Hansel
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-04-08       Impact factor: 2.849

2.  Age-associated abnormalities of intrinsic automaticity of sinoatrial nodal cells are linked to deficient cAMP-PKA-Ca(2+) signaling.

Authors:  Jie Liu; Syevda Sirenko; Magdalena Juhaszova; Steven J Sollott; Shweta Shukla; Yael Yaniv; Edward G Lakatta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

3.  Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease.

Authors:  Rachel M Slaton; Danielle L Cruthirds
Journal:  P T       Date:  2012-02

4.  Urban-rural differences in coronary heart disease mortality in the United States: 1999-2009.

Authors:  Ambar Kulshreshtha; Abhinav Goyal; Kaustubh Dabhadkar; Emir Veledar; Viola Vaccarino
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

5.  NONDRINKER MORTALITY RISK IN THE UNITED STATES.

Authors:  Richard G Rogers; Patrick M Krueger; Richard Miech; Elizabeth M Lawrence; Robert Kemp
Journal:  Popul Res Policy Rev       Date:  2013-06

6.  Tradeoffs in cardiovascular disease prevention, treatment, and research.

Authors:  George Miller; Matthew Daly; Charles Roehrig
Journal:  Health Care Manag Sci       Date:  2012-10-23

7.  Outpatient palliative care for chronic obstructive pulmonary disease: a case series.

Authors:  Clara Schroedl; Susan Yount; Eytan Szmuilowicz; Sharon R Rosenberg; Ravi Kalhan
Journal:  J Palliat Med       Date:  2014-06-16       Impact factor: 2.947

8.  Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.

Authors:  Weston Spivia; Patrick S Magno; Patrick Le; Deborah A Fraser
Journal:  Inflamm Res       Date:  2014-08-05       Impact factor: 4.575

Review 9.  Role of tissue factor in atherothrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

10.  Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease.

Authors:  Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano
Journal:  COPD       Date:  2013-08       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.